MediWound Ltd. SEC filings MDWD

MediWound Ltd. has 397 filings in SEC EDGAR's recent list, going back to Dec 23, 2013. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 5, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Mar 19, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Mar 21, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Mar 16, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 17, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Feb 25, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Feb 25, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Mar 25, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 19, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Feb 21, 2017 Dec 31, 2016
20-F Annual report (foreign issuer) Jan 25, 2016 Dec 31, 2015
20-F Annual report (foreign issuer) Feb 12, 2015 Dec 31, 2014

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
MDWD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Yavne, Israel
SEC filer status
Accelerated filer
SEC CIK
1593984

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.